FY15.2 Phase I Awards

Phase I Awards

Topic Title Company
CBD152-006 Multi-source Aggregation (fusion) of Semantic Tiered Data (MAST) Modus Operandi, Inc.
CBD152-006 Signal Processing for Layered Sensing Vadum
CBD152-006 Wavelet-Based Approach for Signal Processing and Analysis Physical Optics Corporation
CBD152-006 Signal Processing for Layered Sensing Toyon Research Corporation
CBD152-005 High Sensitivity, Low Complexity, Multiplexed Diagnostic Devices Daktari Diagnostics, Inc.
CBD152-005 High Sensitivity, Low Complexity, Multiplexed Diagnostic Devices Paratus Diagnostics, Inc.
CBD152-004 Concurrent identification of Natural Antibiotics-Producing Gene Clusters and Culture Conditions Carrera Biociences
CBD152-004 Producing Novel Biosynthetic Therapeutics from Extreme Microbiomes iXpressGenes, Inc.
CBD152-004 Exploiting Microbiome and Synthetic Biology to Discover and Produce Naturally Occurring Antibiotics Radiant Genomics, Inc.
CBD152-003 Human monoclonal antibodies as countermeasures for T-2 mycotoxin Abzyme Therapeutics LLC
CBD152-003 Exploiting Natural Products-Based Therapeutics for Aflatoxin Mitigation CFD Research Corporation
CBD152-003 Mycotoxin Neutralization Treatment Physical Optics Corporation
CBD152-003 Mycotoxin Adsorption with Hemocompatible Porous Polymer Beads CytoSorbents, Inc.
CBD152-002 Novel Smart Split Neck Seals for Respiratory Protection Triton Systems, Inc.
CBD152-001 Adaptive Lens for Ocular Correction in Respiratory Protection Systems Physical Optics Corporation
CBD152-001 Adjustable Focus Lenses for Respiratory Projection Voxtel, Inc.
Last Update: September 2, 2015